Accelerating Innovations into CarE (AICE) – Validate Program

Back to all Programs

*Intake to the AICE – Validate Program is currently closed and will reopen in the Spring*

What is it?

The Accelerating Innovations into CarE (AICE) – Validate Program supports Alberta’s innovators along their journey developing digital and data-enabled health technology.   

This program will help overcome the hurdles associated with digital health technology commercialization, across the key domains of: 

  • Product Development,  
  • Business Readiness, 
  • Product-Market Fit, and  
  • Regulatory Compliance. 

Health Innovation Cycle1 and the Alberta Innovates Client Journey

AICE – Validate helps innovators and their health innovations along their commercialization journey. The program focuses on a specific milestones of the Health Innovation Cycle across four domains.


The AICE – Validate Program is an exciting opportunity for innovators in Alberta’s digital health ecosystem. 

AICE – Validate complements our other health innovation program offerings by expanding to include earlier-stage development of digital and data-enabled health technologies.      


Applicants who participate in the program can expect the following outcomes:  

  • Progression along the commercialization pathway in multiple areas including Product-Market Fit, Business Readiness, Regulatory Compliance, and Product Development. 
  • Improve Alberta competitiveness in the global digital health innovation sector.


Applicant Eligibility Criteria – To qualify as an Applicant, an entity must be:

  • An Alberta-based post-secondary institution, government entity or health delivery agent; OR
  • A for-profit Small-to-medium enterprise (SME) corporation, defined as having fewer than 500 full time employees, and less than $50,000,000 annual gross revenue, with up to date corporate filings* as a legal entity:
  • Incorporated in Alberta, or
  • Incorporated in another jurisdiction and extra-provincially registered in Alberta, or
  • A General Partnership, Limited Partnership, or Limited Liability Partnership and registered in Alberta; AND
  • Demonstrate completion or near-completion of all milestones associated with “Discovering”, “Ideating”, and “Conceptualizing” stages of the Alberta Innovates Client Journey (see the intake form on the program webpage for milestone details)
  • Demonstrate the relationship between the Applicant and Co-Applicant (if applicable) does not create a conflict of interest;
  • Be an Alberta-based entity with an Albertan footprint, which is determined by the following: significant physical and corporate operational presence in Alberta, appropriate Alberta ownership, and discernable intent that operational benefits will flow primarily within the province of Alberta;
  • Be in good financial standing with Alberta Innovates and its subsidiaries InnoTech Alberta and C-FER Technologies.

*Please note, Alberta Innovates will perform a corporate search and may also seek bankruptcy and litigation searches.


Alberta Innovates will contribute up to $300,000 CAD to support approved projects over a maximum term of 24 months. 

A minimum of 25% of total eligible Project Costs must be provided by the Applicant as cash or in-kind contributions

Application process  

Intake to the AICE – Validate Program is currently closed and will reopen on April 1, 2021.

Application Resources

Additional Supports & Resources 

  • E-Learning Tool – Health Canada – resource intended to educate stakeholders on premarket regulatory requirements for medical devices in Canada. 
  • Alberta Clinical Research Roadmap – an interactive online navigator outlining the steps to setting up and conducting a clinical health research study within Alberta. 
  • ARECCI – helps practitioners, agencies and organizations identify and mitigate ethical risks in program evaluations, quality improvement projects, needs assessments, health innovations and knowledge translation. 
  • Alberta Innovates, Entrepreneurial Investments – Alberta Innovates offers a variety of related high-demand, entrepreneurial investment programs that are of interest to SMEs. 

[1] Adapted from the Consortia for Improving Medicine with Innovation & Technology’s Guidance and Impact Tracking System.